Cargando…

Metabolic pathway analysis of hyperuricaemia patients with hyperlipidaemia based on high-throughput mass spectrometry: a case‒control study

BACKGROUND: Both hyperuricaemia and hyperlipidaemia are common metabolic diseases that are closely related to each other, and both are independent risk factors for the development of a variety of diseases. HUA combined with hyperlipidaemia increases the risk of nonalcoholic fatty liver disease and c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Xue, Jia, Xiaodong, Liu, Rui, Zhang, Sha, Liu, Shixuan, An, Jing, Zhou, Lei, Zhang, Yushi, Mo, Yuanning, Li, Xiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805114/ https://www.ncbi.nlm.nih.gov/pubmed/36585694 http://dx.doi.org/10.1186/s12944-022-01765-0

Ejemplares similares

Correction: Metabolic pathway analysis of hyperuricaemia patients with hyperlipidaemia based on high-throughput mass spectrometry: a case–control study
por: Wei, Xue, et al.
Publicado: (2023)

Effects of hyperuricaemia, with the superposition of being overweight and hyperlipidaemia, on the incidence of acute kidney injury following cardiac surgery: a retrospective cohort study
por: Su, Yiqi, et al.
Publicado: (2022)

Screening for Hyperlipidaemia in Childhood: Recommendations of the British Hyperlipidaemia Association
por: Wray, R, et al.
Publicado: (1996)

The Management of Hyperuricaemia
por: Bayliss, Richard, et al.
Publicado: (1984)

Hyperuricaemia and the metabolic syndrome in type 2 DM
por: Ogbera, Anthonia O, et al.
Publicado: (2010)

Hyperlipidaemia: Diagnosis and Management
por: Betteridge, D J
Publicado: (1996)

Screening for Hyperlipidaemia in Childhood
por: O'Donohue, J M, et al.
Publicado: (1996)

Screening for Hyperlipidaemia in Childhood
por: Pearce, K E, et al.
Publicado: (1996)

Peculiarities of hyperlipidaemia in tumour patients.
por: Dilman, V. M., et al.
Publicado: (1981)

DNA Markers in the Hyperlipidaemias and Atherosclerosis
por: Rees, A.
Publicado: (1987)

Favipiravir: Hyperuricaemia: case report
Publicado: (2021)

Risk of dementia in gout and hyperuricaemia: a meta-analysis of cohort studies
por: Pan, Shu-Yue, et al.
Publicado: (2021)

Hyperuricaemia, gout and allopurinol in the CKD Queensland registry
por: Jeyaruban, A., et al.
Publicado: (2021)

Advances in the management of malignancy-associated hyperuricaemia.
por: Mahmoud, H. H., et al.
Publicado: (1998)

Lessons from treatment resistant hyperlipidaemia
por: Parsons, Elizabeth, et al.
Publicado: (2016)

Guidelines for the Management of Hyperlipidaemia in General Practice
por: Elkeles, R. S.
Publicado: (1992)

Therapeutic impact of stachyose on hyperlipidaemia caused by a high-fat diet in mice as revealed by gut microbiota and metabolomics
por: Zhang, Wensen, et al.
Publicado: (2023)

Association of the variants in the BUD13-ZNF259 genes and the risk of hyperlipidaemia
por: Aung, Lynn Htet Htet, et al.
Publicado: (2014)

Chronopharmacology of simvastatin on hyperlipidaemia in high‐fat diet‐fed obese mice
por: Li, Huan, et al.
Publicado: (2020)

Statin use, hyperlipidaemia, and the risk of breast cancer
por: Kaye, J A, et al.
Publicado: (2002)

The first metatarsophalangeal joint in gout and asymptomatic hyperuricaemia
por: Stewart, Sarah, et al.
Publicado: (2015)

The Management of Hyperlipidaemia: Are Specialist Lipid Clinics Needed?
por: Roche, M., et al.
Publicado: (1992)

Function of Uric Acid Transporters and Their Inhibitors in Hyperuricaemia
por: Sun, Hao-lu, et al.
Publicado: (2021)

Gout and hyperuricaemia: modifiable cardiovascular risk factors?
por: Burnier, Michel
Publicado: (2023)

The illness perception and health promotion behaviour of young and middle‐aged patients with hyperuricaemia: A qualitative study
por: Liu, Li, et al.
Publicado: (2022)

Hyperthyroid and Hypothyroid Status Was Strongly Associated with Gout and Weakly Associated with Hyperuricaemia
por: See, Lai-Chu, et al.
Publicado: (2014)

Alterations of the Gut Microbiome Associated With the Treatment of Hyperuricaemia in Male Rats
por: Yu, Yiran, et al.
Publicado: (2018)

Association between hyperuricaemia and hand osteoarthritis: data from the Xiangya Osteoarthritis Study
por: Zhu, Yanqiu, et al.
Publicado: (2023)

A multiethnic association analysis of hyperuricaemia with cardiovascular risk in rural and urban areas in Chinese adults
por: Liu, Leilei, et al.
Publicado: (2021)

Associations of PRKN–PACRG SNPs and G × G and G × E interactions with the risk of hyperlipidaemia
por: Zheng, Peng-Fei, et al.
Publicado: (2020)

Fixed drug combination in hypertension and hyperlipidaemia in the developing world
por: Seedat, YK
Publicado: (2008)

Incident gout and erectile dysfunction: is hyperuricaemia the elephant in the room?
por: Abhishek, Abhishek, et al.
Publicado: (2017)

Hyperuricaemia in Cardiovascular Diseases: A Passive or an Active Player?
por: Katsiki, Niki, et al.
Publicado: (2015)

Celecoxib exhibits therapeutic potential in experimental model of hyperlipidaemia
por: Ekor, Martins, et al.
Publicado: (2021)

Hyperuricaemia: prevalence and association with mortality in an elderly Finnish population
por: Timsans, Janis, et al.
Publicado: (2023)

LncRNA‐HOTAIR promotes endothelial cell pyroptosis by regulating the miR‐22/NLRP3 axis in hyperuricaemia
por: Chi, Kun, et al.
Publicado: (2021)

SYNE1‐QK1 SNPs, G × G and G × E interactions on the risk of hyperlipidaemia
por: Zheng, Peng‐Fei, et al.
Publicado: (2020)

High‐Throughput Single‐Cell Mass Spectrometry Reveals Abnormal Lipid Metabolism in Pancreatic Ductal Adenocarcinoma
por: Liu, Qinlei, et al.
Publicado: (2021)

Advances in high‐throughput mass spectrometry in drug discovery
por: Dueñas, Maria Emilia, et al.
Publicado: (2022)

High prevalence of hyperuricaemia and its impact on non-valvular atrial fibrillation: the cross-sectional Guangzhou (China) Heart Study
por: Lin, Wei-dong, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_apf2n1l5rptdis5b1t28shd7hk